The Role of Intraperitoneal Chemotherapy in Treatment of Primary& Recurrent Epithelial Ovarian Carcinoma
Rasha Salama Mohammed;
Abstract
A combination of IV and IP administration of chemotherapy conveys a significant survival benefit among women with optimally debulked epithelial ovarian cancer, compared to IV administration alone.
The three largest studies with the greatest survival adv
The three largest studies with the greatest survival adv
Other data
| Title | The Role of Intraperitoneal Chemotherapy in Treatment of Primary& Recurrent Epithelial Ovarian Carcinoma | Other Titles | دراسة عن دور حقن العلاج الكيمائيي داخل الغشاء البريتونى في المرضى الذين يعانون من الاورام الاولية والمرتجعة لغشاء المبيض | Authors | Rasha Salama Mohammed | Keywords | The Role of Intraperitoneal Chemotherapy in Treatment of Primary& Recurrent Epithelial Ovarian Carcinoma | Issue Date | 2009 | Description | A combination of IV and IP administration of chemotherapy conveys a significant survival benefit among women with optimally debulked epithelial ovarian cancer, compared to IV administration alone. The three largest studies with the greatest survival adv |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 944212282.pdf | 388.33 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.